Related Experiment Video

Updated: Apr 20, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.9K

BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis

Lidia Sabater1, Manuel Gómez-Choco, Albert Saiz

  • 1Service of Neurology, Hospital Clinic, Universitat de Barcelona and Institut d' Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Journal of Neuroimmunology
|September 17, 2005
PubMed

Insights

Researchers identified BR serine/threonine kinase 2 (BRSK2) as a potential autoantigen in limbic encephalitis associated with small-cell lung cancer (SCLC). This discovery may advance understanding of paraneoplastic neurological syndromes.

Area of Science:

  • Neuroimmunology
  • Oncology

Background:

  • Paraneoplastic neurological syndromes (PNS) can be triggered by cancers, leading to autoimmune responses against neuronal targets.
  • Small-cell lung cancer (SCLC) is frequently associated with PNS, including limbic encephalitis.

Observation:

  • Antibodies in a patient with limbic encephalitis and SCLC recognized a novel antigen in rat brain and testis.
  • Immunohistochemistry and immunoblotting revealed specific protein bands, leading to the isolation of BR serine/threonine kinase 2 (BRSK2).

Findings:

  • BRSK2, also known as SAD1B kinase, is preferentially expressed in the brain and testis and plays a role in neuronal polarization and synaptic development.
  • Antibodies against BRSK2 were detected in SCLC patients, suggesting its potential role as an autoantigen in SCLC-associated limbic encephalitis.
  • BRSK2 antibodies were not found in control groups, including SCLC patients without PNS and individuals with other neurological conditions.

Implications:

  • BRSK2 may serve as a novel diagnostic biomarker for SCLC-associated limbic encephalitis.
  • Understanding BRSK2's role could lead to targeted immunotherapies for paraneoplastic neurological disorders.
  • This finding expands the spectrum of known onconeural antigens involved in cancer-related neurological autoimmunity.

More Related Videos

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on: June 29, 2016

14.7K
Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis08:20

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Published on: June 2, 2022

4.1K

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
5
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
9
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
17
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
21